A phase 2 randomised controlled trial published in the New England Journal of Medicine (2023) reported substantial weight loss and improvements in glycaemic parameters, though the trial was conducted in a closely monitored clinical setting with defined eligibility criteria
Results depend heavily on maintaining proper diet and exercise alongside peptide therapy
If approved, youll get your medication and ongoing support
Projected retatrutide availability in Canada: 2027-2028
J Clin Endocrinol Metab (1995) 80:9527
Thank you to our sponsors AG1: LMNT: David: Timestamps (00:00:00) Kyle Gillett (00:00:20) Male Hormone Optimization, Testosterone, Tool: Blood Tests (00:02:17) Diet & Hormone Health, Diary, Vitamin D, Fiber (00:05:36) Caloric Restriction & Testosterone (00:06:44) Lifestyle Pillars: Stress, Life Purpose (00:07:56) Sponsor: LMNT (00:09:28) Exercise & Hormone Health (00:10:32) Testosterone Replacement Therapy (TRT) & Young Adults (00:12:05) Supplements for Testosterone, Creatine & Hair Loss